Skip to main content
Top
Published in: International Urology and Nephrology 4/2013

01-08-2013 | Urology - Original Paper

The volume of prostate can impact the male sexual function following photoselective vaporization of the prostate: results of a prospective analysis of 128 patients with 2-year follow-up

Authors: Zhen Guo, Xunbo Jin

Published in: International Urology and Nephrology | Issue 4/2013

Login to get access

Abstract

Objective

To evaluate the impact of the male sexual function following photoselective vaporization of the prostate treatment in different volume of prostates.

Methods

One hundred and twenty-eight consecutive patients with active sexual ability who underwent prostate vaporization with the green light laser during 2009–2011 were enrolled. We divided all patients into two groups group I (<70 ml, n = 58) and group II (≥70 ml, n = 70) according to the volume of prostate. Two group patients were assessed by International Index of Erectile Function (IIEF-5) preoperatively and at 1, 3, 6, 12, and 24 months. We measured the IPSS, QoL, Q max, PRV PSA at the baseline, postoperation and every visit. IIF-5 questionnaires were also collected in every visit.

Result

One hundred and twenty-eight patients were under successful operations. In the 1, 3, 6, 12 and 24 months, main parameters following operation such as Q max PRV IPSS and QoL scores had significant improved compared to baseline. However, the group II was better than group I in every visits. As the 6, 12 and 24 months of questionnaires, group II had less IIEF scores than group I. To evaluate the adverse sexual outcomes of IIEF-5 lists, the erectile dysfunction and overall unsatisfied scores of group II were much more than group I in 6–24-month visits.

Conclusion

The larger volume of prostate (≥70 ml) following PVP treatment has negative influence on sexual function in the long term (more than 6 months). The adverse sexual outcomes were significant increased after PVP in the prostate with more than 70-ml volume.
Literature
1.
go back to reference Walsh PC, Retik AB, Stamey TA et al (1992) Benign prostatic hyperplasia. In: Walsh PC, Retile AB, Stamey T (eds) Campbell’s urology, 6th edn. WB Saunders, Philadelphia, pp 1007–1027 Walsh PC, Retik AB, Stamey TA et al (1992) Benign prostatic hyperplasia. In: Walsh PC, Retile AB, Stamey T (eds) Campbell’s urology, 6th edn. WB Saunders, Philadelphia, pp 1007–1027
2.
go back to reference Jones C, Hill J, Chapple C (2010) Guideline development group. Management of lower urinary tract symptoms in men: summary of NICE guidance. BMJ 340:c2354PubMedCrossRef Jones C, Hill J, Chapple C (2010) Guideline development group. Management of lower urinary tract symptoms in men: summary of NICE guidance. BMJ 340:c2354PubMedCrossRef
3.
go back to reference Teng J, Zhang D, Li Y et al (2013) Photoselective vaporization with the green light laser versus transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int 111(2):312–323PubMedCrossRef Teng J, Zhang D, Li Y et al (2013) Photoselective vaporization with the green light laser versus transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int 111(2):312–323PubMedCrossRef
4.
go back to reference Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:55–349CrossRef Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:55–349CrossRef
5.
go back to reference Ruszat R, Wyler S, Forster T (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51:41–1031 discussion 1038-41CrossRef Ruszat R, Wyler S, Forster T (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51:41–1031 discussion 1038-41CrossRef
6.
go back to reference Ruszat R, Seitz M, Wyler SF et al (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893–901PubMedCrossRef Ruszat R, Seitz M, Wyler SF et al (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893–901PubMedCrossRef
7.
go back to reference Yu H, Wu H, Rao D (2012) Analysis of the therapeutic effect of tadalafil on male ED after transurethral resection of prostate. Int J Impot Res 24(4):147–149PubMedCrossRef Yu H, Wu H, Rao D (2012) Analysis of the therapeutic effect of tadalafil on male ED after transurethral resection of prostate. Int J Impot Res 24(4):147–149PubMedCrossRef
8.
go back to reference Muntener M, Aellig S, Kuettel R et al (2007) Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol 52(2):510–515PubMedCrossRef Muntener M, Aellig S, Kuettel R et al (2007) Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol 52(2):510–515PubMedCrossRef
9.
go back to reference Elshal AM, Elmansy HM, Elkoushy MA et al (2012) Male sexual function outcome after three laser prostate surgical techniques: a single center perspective. Urology 80(5):1098–1104PubMedCrossRef Elshal AM, Elmansy HM, Elkoushy MA et al (2012) Male sexual function outcome after three laser prostate surgical techniques: a single center perspective. Urology 80(5):1098–1104PubMedCrossRef
10.
go back to reference Naspro R, Bachmann A, Gilling P et al (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Uro 55:1345–1357CrossRef Naspro R, Bachmann A, Gilling P et al (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Uro 55:1345–1357CrossRef
11.
go back to reference Paick JS, Um JM, Kim SW et al (2007) Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 4:1701–1707PubMedCrossRef Paick JS, Um JM, Kim SW et al (2007) Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 4:1701–1707PubMedCrossRef
12.
go back to reference Bruyère F, Puichaud A, Pereira H et al (2010) Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 58:207–211PubMedCrossRef Bruyère F, Puichaud A, Pereira H et al (2010) Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 58:207–211PubMedCrossRef
13.
go back to reference Reich O, Bachmann A, Schneede P et al (2004) Experimental comparison of high power(80 W) potassium titanyl-phosphate laser vaporization and transurethral resection of the prostate. Urol 171:2502–2504CrossRef Reich O, Bachmann A, Schneede P et al (2004) Experimental comparison of high power(80 W) potassium titanyl-phosphate laser vaporization and transurethral resection of the prostate. Urol 171:2502–2504CrossRef
14.
go back to reference Lee R, Saini R, Zoltan E, Te AE (2008) Photoselective vaporization of the prostate using a laser high performance system in the canine model. Urol 180:1551–1553CrossRef Lee R, Saini R, Zoltan E, Te AE (2008) Photoselective vaporization of the prostate using a laser high performance system in the canine model. Urol 180:1551–1553CrossRef
15.
go back to reference Elshal AM, Elmansy HM, Elkoushy MA et al (2012) Male sexual function outcome after three laser prostate surgical techniques: a single center perspective. Urology 80:1098–1104PubMedCrossRef Elshal AM, Elmansy HM, Elkoushy MA et al (2012) Male sexual function outcome after three laser prostate surgical techniques: a single center perspective. Urology 80:1098–1104PubMedCrossRef
16.
go back to reference Kavoussi PK, Hermans MR (2008) Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. Sex Med 5:2669–2671CrossRef Kavoussi PK, Hermans MR (2008) Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. Sex Med 5:2669–2671CrossRef
17.
go back to reference Hamann MF, Naumann CM, Seif C et al (2008) Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 54:902–910PubMedCrossRef Hamann MF, Naumann CM, Seif C et al (2008) Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 54:902–910PubMedCrossRef
Metadata
Title
The volume of prostate can impact the male sexual function following photoselective vaporization of the prostate: results of a prospective analysis of 128 patients with 2-year follow-up
Authors
Zhen Guo
Xunbo Jin
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0489-9

Other articles of this Issue 4/2013

International Urology and Nephrology 4/2013 Go to the issue

Nephrology - Review

Informatic nephrology

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.